產(chǎn)品推薦:氣相|液相|光譜|質(zhì)譜|電化學|元素分析|水分測定儀|樣品前處理|試驗機|培養(yǎng)箱


化工儀器網(wǎng)>技術中心>報價單>正文

歡迎聯(lián)系我

有什么可以幫您? 在線咨詢

Utrophin抗原,肌營養(yǎng)不良蛋白相關蛋白1抗原

  • 資料類型

    jpg
  • 文件大小

    31.5KB
  • 瀏覽次數(shù)

    13次
  • 上傳時間

    2024年12月18日
關鍵詞
Utrophin,Utrophin抗體,肌營養(yǎng)不良蛋白相關蛋白1,肌營養(yǎng)不良蛋白相關蛋白1抗體,重組
上傳者
上海允麥生物科技有限公司
立即下載

資料簡介

Recombinant human Utrophin   

DHTX; Disrupted in heterotaxy; p63; UV radiation resistance associated; UV radiation resistance associated gene; UV radiation resistance associated gene protein; UV radiation resistance-associated gene protein; UtrophinUtrophin_HUMAN.    

濃度:1mg/ ml

來源:Recombinant Human

純度:≥95% SDS-PAGE

表達系統(tǒng):Wheat germ

標簽:GST tag N-Terminus

蛋白長度:Protein fragment

內(nèi)毒素水平:<1.000 Eu/µg

純化方法:HPLC

應用:SDS-PAGE,Western blot,ELISA

Biological activity,immunology research

保存:-20℃

保質(zhì)期:1年

Dystrophin and utrophin are related structural, Actin-binding proteins that are involved in anchoring the cytoskeleton to the plasma membrane. Dystrophin is the protein product of the Duchenne/Becker muscular dystrophy gene. Dystrophin expression is found in muscle and brain tissues, where it is localized to the inner surface of the plasma membrane. It has been speculated that alternative splicing of the carboxy terminus allows dystrophin to interact with a variety of proteins. Research has shown that the loss of dystrophin-associated proteins in Duchenne afflicted muscle is due to the absence of dystrophin rather than to muscle degradation and that the lack of dystrophin results in the loss of linkage between the cytoskeleton and the extracellular matrix. Evidence suggests that the upregulation of utrophin can reduce the dystrophic pathology.


抗體

產(chǎn)品名稱:Rabbit Anti-Utrophin antibody

Rabbit Anti-Utrophin  

別名:DMDL; DRP 1; DRP; DRP-1; DRP1; Dystrophin like protein; Dystrophin related protein 1; Dystrophin related protein; Dystrophin-related protein 1; FLJ23678; UTRN; UTRO_HUMAN; Utrophin (homologous to dystrophin); Utrophin     

來源:Rabbit

克隆類型:Polyclonal

濃度:1mg/ml

亞型:IgG

應用: WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反應:Human (predicted: Mouse,Rat,Pig,Sheep,Cow,Chicken,Dog)

理論分子量:394kDa

免疫原:KLH conjugated synthetic peptide derived from Human Utrophin 

保存:-20
保質(zhì)期:1

 

單克隆抗體

產(chǎn)品名稱:Anti-Utrophin antibody

Mouse Anti-Utrophin 

別名:DMDL; DRP 1; DRP; DRP-1; DRP1; Dystrophin like protein; Dystrophin related protein 1; Dystrophin related protein; Dystrophin-related protein 1; FLJ23678; UTRN; UTRO_HUMAN; Utrophin (homologous to dystrophin); Utrophin  

來源:Mouse

克隆類型:Monoclonal

濃度:1mg/ml

亞型:IgG

應用: WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反應: Human 

理論分子量:394kDa

免疫原:KLH conjugated synthetic peptide derived from Human Utrophin  

保存:-20
保質(zhì)期:1

Dystrophin and utrophin are related structural, Actin-binding proteins that are involved in anchoring the cytoskeleton to the plasma membrane. Dystrophin is the protein product of the Duchenne/Becker muscular dystrophy gene. Dystrophin expression is found in muscle and brain tissues, where it is localized to the inner surface of the plasma membrane. It has been speculated that alternative splicing of the carboxy terminus allows dystrophin to interact with a variety of proteins. Research has shown that the loss of dystrophin-associated proteins in Duchenne afflicted muscle is due to the absence of dystrophin rather than to muscle degradation and that the lack of dystrophin results in the loss of linkage between the cytoskeleton and the extracellular matrix. Evidence suggests that the upregulation of utrophin can reduce the dystrophic pathology.

 

 


免責聲明

  • 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡有限公司-化工儀器網(wǎng)合法擁有版權或有權使用的作品,未經(jīng)本網(wǎng)授權不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)授權使用作品的,應在授權范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關法律責任。
  • 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權等法律責任。
  • 如涉及作品內(nèi)容、版權等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關權利。
企業(yè)未開通此功能
詳詢客服 : 0571-87858618